Indicated for the treatment of adult patients with: 🔹 Multiple Myeloma (MM): As combination therapy or maintenance treatment following autologous stem cell transplantation. 🔹 Myelodysplastic Syndromes (MDS): Specifically for transfusion-dependent anemia associated with a deletion 5q cytogenetic abnormality. 🔹 Mantle Cell Lymphoma (MCL): For patients who have relapsed or progressed after other treatments.

Dosage and administration

Sales Unit: Box of 21 capsules (3 strips of 7), 10 mg strength. ⚠️ APPLICATION INSTRUCTIONS: Administration: Swallow capsules whole with water at the same time each day. Do not break, chew, or open. Standard Cycle: Typically taken on days 1-21 of repeated 28-day cycles. Dose Modification: This 10 mg strength allows for precise dose reduction in patients experiencing adverse events or with renal impairment. ✋ Safety Warning: Pregnant women must not handle the blister or capsule due to risk of absorption through the skin.

⛔ Pregnancy & Breastfeeding: STRICTLY CONTRAINDICATED. Known to cause severe birth defects. Women of childbearing potential (unless adhering to a strict pregnancy prevention program). Children under 18 years of age. Hypersensitivity to Lenalidomide. Severe renal failure (requires careful monitoring).

Strict medical supervision is required. Common side effects include: 📉 Blood Disorders: Neutropenia (low white blood cells), thrombocytopenia, and anemia. Weekly blood tests are often required initially. 🩸 Clotting Risk: Increased risk of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). 🤢 Systemic: Fatigue, gastrointestinal issues (diarrhea/constipation), rash, and muscle spasms.

Revlixen 10 — Lenalidomide 10 mg, 21 product-page.units_short, Everest

100% original product

Active ingredient

Lenalidomide

Manufacturer

Everest

Dosage 10 mg

Dosage form Capsules

Capsules per pack 21

Revlixen 10 Capsules — Lenalidomide 10 mg (21 Caps) Everest

Name: Revlixen 10
Brand: Everest
SKU: PROD-194
Price: 4170 UAH
Availability: InStock

4170₴ ~~5048₴~~ -17%

Revlixen 10 (Lenalidomide) is an immunomodulatory drug and a generic equivalent to Revlimid, provided in a 10 mg strength. It works by affecting the body's immune system and directly attacking cancer cells.

Manufacturer: Everest Pharmaceuticals (Bangladesh). The 10 mg dosage is often used for dose adjustments based on patient tolerance or renal function, while maintaining efficacy against tumor growth.

Key Features:

✅ Anti-Angiogenesis: Blocks the development of new blood vessels needed by tumors to grow.
✅ Tumor Suppression: Directly inhibits the proliferation of malignant cells.
✅ Immune Activation: Enhances the activity of T-cells and Natural Killer cells against cancer.

Indicated for the treatment of adult patients with:

🔹 Multiple Myeloma (MM): As combination therapy or maintenance treatment following autologous stem cell transplantation.
🔹 Myelodysplastic Syndromes (MDS): Specifically for transfusion-dependent anemia associated with a deletion 5q cytogenetic abnormality.
🔹 Mantle Cell Lymphoma (MCL): For patients who have relapsed or progressed after other treatments.

Sales Unit: Box of 21 capsules (3 strips of 7), 10 mg strength.

⚠️ APPLICATION INSTRUCTIONS:

Administration: Swallow capsules whole with water at the same time each day. Do not break, chew, or open.
Standard Cycle: Typically taken on days 1-21 of repeated 28-day cycles.
Dose Modification: This 10 mg strength allows for precise dose reduction in patients experiencing adverse events or with renal impairment.
✋ Safety Warning: Pregnant women must not handle the blister or capsule due to risk of absorption through the skin.

⛔ Pregnancy & Breastfeeding: STRICTLY CONTRAINDICATED. Known to cause severe birth defects.
Women of childbearing potential (unless adhering to a strict pregnancy prevention program).
Children under 18 years of age.
Hypersensitivity to Lenalidomide.
Severe renal failure (requires careful monitoring).

Strict medical supervision is required. Common side effects include:

📉 Blood Disorders: Neutropenia (low white blood cells), thrombocytopenia, and anemia. Weekly blood tests are often required initially.
🩸 Clotting Risk: Increased risk of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE).
🤢 Systemic: Fatigue, gastrointestinal issues (diarrhea/constipation), rash, and muscle spasms.